BIONUTRAL
ActiveSummary
The computed 12-month bankruptcy probability of BIONUTRAL is 2.2% (moderate). The 2025 annual accounts show negative equity (-€66,179) and a net result of -€10,842. Equity is shrinking by about 15% per year across the filed financial years. Its solvency ranks better than 6% of 13,595 sector peers (NACE 46, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
11-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2018 to 2025net €1,043 ▲209%
Operating result €1,014, net result €1,043, both a record.
02-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
11-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Back to profitnet €986
Net result €986 after 4 loss-making years.
31-12
Financial
Liquidity more than 10 timescurrent ratio 3.86
Current ratio from 0.37 to 3.86; short-term debt falls from €129,275 to €9,021.
20-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
28-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial
Liquidity more than doubledcurrent ratio 11.87
Current ratio from 5.27 to 11.87; short-term debt falls from €12,529 to €6,108.
17-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-12
Financial
Liquidity more than 15 timescurrent ratio 5.27
Current ratio from 0.34 to 5.27; short-term debt falls from €140,645 to €12,529.
08-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 5 deeds read
About the unread acts
We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.